title: Immune responses after mesenchymal stem cell implantation.
abstract: Stem cell transplantation is a promising approach for improving cardiac function after severe myocardial damage for which use of autologous cells have been preferred to avoid immune rejection. Recently, however, rodent as well as human mesenchymal stromal cells (MSCs) have been reported to be uniquely immune tolerant, both in in vitro as well as in vivo transplant models. In this chapter, we summarize the current understanding of the underlying immunologic mechanisms, which can facilitate the use of such cells as "universal donor cells."
authors.affiliation: Division of Cardiac Surgery, Health Sciences North Sudbury, Greater Sudbury, ON, Canada.
authors.forename: Rony
authors.initials: R
authors.lastname: Atoui
authors.forename: Ray C J
authors.initials: RC
authors.lastname: Chiu
mesh_terms: D000818:Animals; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000276:immunology*; D009203:Myocardial Infarction / Q000276:immunology* / Q000628:therapy